We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Invited Commentary |

Abuse-Deterrent Opioid Formulations Part of a Public Health Strategy to Reverse the Opioid Epidemic

Hillary V. Kunins, MD, MPH, MS1
[+] Author Affiliations
1New York City Department of Health and Mental Hygiene, Queens, New York
JAMA Intern Med. 2015;175(6):987-988. doi:10.1001/jamainternmed.2015.0939.
Text Size: A A A
Published online


Rapid increases in the supply of opioid analgesics have largely driven the nearly unremitting increase in overdose deaths in the United States, which have grown by more than 150% over the past decade, from 16 849 in 1999 to 41 502 in 2012.1,2 Since the 1990s, opioid analgesic sales have increased more than 4-fold, with rising and widely variable regional prescribing patterns. Increased market supply makes opioids more available for misuse and diversion to people engaging in recreational use and to people with addiction. In both cases, misuse and diversion increase, elevating population overdose risk. In fact, geographic areas with higher opioid prescribing rates experience higher overdose rates.2 In addition, patient-level data demonstrate that the intensity of opioid exposure, including higher prescribed doses and longer duration of therapy, elevates overdose risk.3,4 Given this opioid-overdose epidemic, the clinical literature is understandably replete with efforts that target individuals most at risk, including strategies such as routine screening for risk of addiction, patient agreements, and urine toxicology monitoring. Unfortunately, these approaches have not yet demonstrated widespread effectiveness in reversing the epidemic.5

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment
abuse deterrent meds causing more OD's?
Posted on April 22, 2015
Mitchell Simson MD, MPH
University of New Mexico School of Medicine
Conflict of Interest: None Declared
Interesting that the marketing of the newer abuse deterrent formulations of opioids has been associated with a tremendous increase in the number of heroin overdoses. Perhaps identifying and treating those with an opioid use disorder would be as helpful.
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

2 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles

Care at the Close of Life: Evidence and Experience
Use of Opioid Analgesics for a Pain Crisis in an Inpatient Setting

Care at the Close of Life: Evidence and Experience
Pain Management and Symptomatic Measures